Skip to main content
Top

Breast Cancer Research

Issue 3/2006

Content (15 Articles)

Commentary

Bone versus breast density

Jack Cuzick

Open Access Research article

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

Laurel A Habel, Steven Shak, Marlena K Jacobs, Angela Capra, Claire Alexander, Mylan Pho, Joffre Baker, Michael Walker, Drew Watson, James Hackett, Noelle T Blick, Deborah Greenberg, Louis Fehrenbacher, Bryan Langholz, Charles P Quesenberry

Erratum

Erratum to: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Trevor Powles, Alexander Paterson, Eugene McCloskey, Phil Schein, Bobbi Scheffler, Alwynne Tidy, Sue Ashley, Ian Smith, Lars Ottestad, John Kanis

Review

What can be learnt from models of incidence rates?

Graham A Colditz, Bernard A Rosner

Open Access Research article

Variation in the RAD51 gene and familial breast cancer

Felicity Lose, Paul Lovelock, Georgia Chenevix-Trench, Graham J Mann, Gulietta M Pupo, Amanda B Spurdle

Open Access Research article

The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis

Bernard Têtu, Jacques Brisson, Chang Shu Wang, Hélène Lapointe, Geneviève Beaudry, Caty Blanchette, Dominique Trudel

Open Access Research article

Keratin 6 is not essential for mammary gland development

Sandra L Grimm, Wen Bu, Mary Ann Longley, Dennis R Roop, Yi Li, Jeffrey M Rosen

Open Access Research article

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

Vasso Apostolopoulos, Geoffrey A Pietersz, Anastasios Tsibanis, Annivas Tsikkinis, Heleni Drakaki, Bruce E Loveland, Sara J Piddlesden, Magdalena Plebanski, Dodie S Pouniotis, Michael N Alexis, Ian F McKenzie, Stamatis Vassilaros

Open Access Research article

The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis

Susan J Cleator, Trevor J Powles, Tim Dexter, Laura Fulford, Alan Mackay, Ian E Smith, Haukur Valgeirsson, Alan Ashworth, Mitch Dowsett

Open Access Research article

The association of mammographic density with ductal carcinoma in situof the breast: the Multiethnic Cohort

Jasmeet K Gill, Gertraud Maskarinec, Ian Pagano, Laurence N Kolonel

Open Access Research article

Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer

Russell Burcombe, George D Wilson, Mitch Dowsett, Ifty Khan, Paul I Richman, Frances Daley, Simone Detre, Andreas Makris

Open Access Research article

Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1

Kheng Tian Lim, Niamh Cosgrave, Arnold David Hill, Leonie S Young

Review

Array-CGH and breast cancer

Erik H van Beers, Petra M Nederlof

Review

Breast cancer, stem cells and prospects for therapy

Magnus D Lynch, Massimiliano Cariati, Anand D Purushotham

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine